North America Swine Healthcare Market: By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country Forecast 2020-2031
North America Swine Healthcare Market size was valued at US$ 2.94 billion in 2024 and is expected to reach US$ 5.09 billion by 2031, growing at a significant CAGR of 8.2% from 2025-2031. Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. The market becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases. Drivers are Increase in the demand for healthy pork meat coupled with rise in number of pork meat industries, Rise in prevalence of various infectious and foodborne diseases and Increase in the R&D activities for the innovation of novel therapeutics and feed products. Restraints are Stringent regulatory guidelines for the swine vaccines and drug approvals and Adverse effects associated with the drugs.
North America Swine Healthcare Market is expected to be driven by rising cases of swine diseases and increased investments in research and development activities for generating novel treatments to suit medical needs.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 2.94 billion |
|
Market Size in 2031 |
US$ 5.09 billion |
|
By Product Type |
|
|
By Disease Type |
|
|
By Route-administration |
|
|
By Distribution Channel |
|
Download Free Sample Report
North America Swine Healthcare Market size was valued at US$ 2.94 billion in 2024 and is expected to reach US$ 5.09 billion by 2031, growing at a significant CAGR of 8.2% from 2025-2031.
The report covers the countries market data: United States, Canada
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Zoetis , Merck & Co, Virbac S.A., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health , Ceva Sante Animale , Wilbur-Ellis Feed, LLC, Vetoquinol S.A.
| 1.Executive Summary |
| 2. North America Swine Healthcare Market Introduction |
| 2.1. North America Swine Healthcare Market - Taxonomy |
| 2.2. North America Swine Healthcare Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Disease Type |
| 2.2.3.Route of Administration |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3. North America Swine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. North America Swine Healthcare Market Analysis, 2020-2024 and Forecast 2025-2031 |
| 4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. North America Swine Healthcare Market By Product Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 5.1. Drugs |
| 5.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Feed Products |
| 5.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. North America Swine Healthcare Market By Disease Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 6.1. Viral Infections |
| 6.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bacterial Infections |
| 6.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasitic Infection |
| 6.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Fungal Infections |
| 6.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. North America Swine Healthcare Market By Route of Administration, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 7.1. Oral |
| 7.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Parenteral |
| 7.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. North America Swine Healthcare Market By Distribution Channel, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 8.1. Veterinary Hospitals |
| 8.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Veterinary Pharmacies, |
| 8.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. North America Swine Healthcare Market By Country, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 9.1. United States of America (USA) |
| 9.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Canada |
| 9.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 10.United States of America (USA) North America Swine Healthcare Market , 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drugs |
| 10.1.2.Feed Products |
| 10.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Infections |
| 10.2.2.Bacterial Infections |
| 10.2.3.Parasitic Infection |
| 10.2.4.Fungal Infections |
| 10.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oral |
| 10.3.2.Parenteral |
| 10.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Veterinary Hospitals |
| 10.4.2.Veterinary Pharmacies, |
| 10.4.3.Online Pharmacies |
| 11.Canada North America Swine Healthcare Market , 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drugs |
| 11.1.2.Feed Products |
| 11.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Infections |
| 11.2.2.Bacterial Infections |
| 11.2.3.Parasitic Infection |
| 11.2.4.Fungal Infections |
| 11.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oral |
| 11.3.2.Parenteral |
| 11.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Veterinary Hospitals |
| 11.4.2.Veterinary Pharmacies, |
| 11.4.3.Online Pharmacies |
| 12.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Infections |
| 12.2.2.Bacterial Infections |
| 12.2.3.Parasitic Infection |
| 12.2.4.Fungal Infections |
| 12.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oral |
| 12.3.2.Parenteral |
| 12.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Veterinary Hospitals |
| 12.4.2.Veterinary Pharmacies, |
| 12.4.3.Online Pharmacies |
| 13.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Infections |
| 13.2.2.Bacterial Infections |
| 13.2.3.Parasitic Infection |
| 13.2.4.Fungal Infections |
| 13.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oral |
| 13.3.2.Parenteral |
| 13.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Veterinary Hospitals |
| 13.4.2.Veterinary Pharmacies, |
| 13.4.3.Online Pharmacies |
| 14.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Viral Infections |
| 14.2.2.Bacterial Infections |
| 14.2.3.Parasitic Infection |
| 14.2.4.Fungal Infections |
| 14.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Oral |
| 14.3.2.Parenteral |
| 14.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Veterinary Hospitals |
| 14.4.2.Veterinary Pharmacies, |
| 14.4.3.Online Pharmacies |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 15.2.2.Merck & Co. Inc. (U.S) |
| 15.2.3.Virbac S.A. (France) |
| 15.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 15.2.5.Elanco (U.S.) |
| 15.2.6.Bayer Animal Health (Germany) |
| 15.2.7.Ceva Sante Animale (France) |
| 15.2.8.Wilbur-Ellis Feed, LLC (U.S.) |
| 15.2.9.Vetoquinol S.A. (France) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Sample
